203 related articles for article (PubMed ID: 31181490)
1. Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions.
Grumann C; Henkel K; Stratford A; Hermanns-Clausen M; Passie T; Brandt SD; Auwärter V
J Pharm Biomed Anal; 2019 Sep; 174():270-276. PubMed ID: 31181490
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases.
Dolder PC; Liechti ME; Rentsch KM
Anal Bioanal Chem; 2015 Feb; 407(6):1577-84. PubMed ID: 25542574
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC-MS/MS and its application to forensic cases.
Jang M; Kim J; Han I; Yang W
J Pharm Biomed Anal; 2015 Nov; 115():138-43. PubMed ID: 26188861
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.
Wagmann L; Richter LHJ; Kehl T; Wack F; Bergstrand MP; Brandt SD; Stratford A; Maurer HH; Meyer MR
Anal Bioanal Chem; 2019 Jul; 411(19):4751-4763. PubMed ID: 30617391
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.
Dolder PC; Liechti ME; Rentsch KM
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28548305
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans.
Steuer AE; Poetzsch M; Stock L; Eisenbeiss L; Schmid Y; Liechti ME; Kraemer T
Drug Test Anal; 2017 May; 9(5):788-797. PubMed ID: 27422082
[TBL] [Abstract][Full Text] [Related]
7. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood.
Sklerov JH; Magluilo J; Shannon KK; Smith ML
J Anal Toxicol; 2000 Oct; 24(7):543-9. PubMed ID: 11043657
[TBL] [Abstract][Full Text] [Related]
8. Return of the lysergamides. Part III: Analytical characterization of N
Brandt SD; Kavanagh PV; Westphal F; Elliott SP; Wallach J; Stratford A; Nichols DE; Halberstadt AL
Drug Test Anal; 2017 Oct; 9(10):1641-1649. PubMed ID: 28342178
[TBL] [Abstract][Full Text] [Related]
9. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation.
de Kanel J; Vickery WE; Waldner B; Monahan RM; Diamond FX
J Forensic Sci; 1998 May; 43(3):622-5. PubMed ID: 9608700
[TBL] [Abstract][Full Text] [Related]
10. LC-mS analysis of human urine specimens for 2-oxo-3-hydroxy LSD: method validation for potential interferants and stability study of 2-oxo-3-hydroxy LSD under various storage conditions.
Klette KL; Horn CK; Stout PR; Anderson CJ
J Anal Toxicol; 2002; 26(4):193-200. PubMed ID: 12054358
[TBL] [Abstract][Full Text] [Related]
11. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Odland AU; Klein AK; Dowling G; Dempster NM; Wallach J; Passie T; Halberstadt AL
Drug Test Anal; 2020 Jun; 12(6):812-826. PubMed ID: 32180350
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and subjective effects of 1P-LSD in humans after oral and intravenous administration.
Grumann C; Henkel K; Brandt SD; Stratford A; Passie T; Auwärter V
Drug Test Anal; 2020 Aug; 12(8):1144-1153. PubMed ID: 32415750
[TBL] [Abstract][Full Text] [Related]
13. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
[TBL] [Abstract][Full Text] [Related]
14. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
Mardal M; Johansen SS; Thomsen R; Linnet K
Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722
[TBL] [Abstract][Full Text] [Related]
15. Characterization of iso-LSD metabolism using human liver microsomes in comparison to LSD and its applicability as urinary biomarker for LSD consumption.
Ng XQ; Goh EML; Hamzah A; Yao YJ; Moy HY
J Anal Toxicol; 2024 Jun; 48(5):281-288. PubMed ID: 38613436
[TBL] [Abstract][Full Text] [Related]
16. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD.
Poch GK; Klette KL; Hallare DA; Manglicmot MG; Czarny RJ; McWhorter LK; Anderson CJ
J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):23-33. PubMed ID: 10202954
[TBL] [Abstract][Full Text] [Related]
17. Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.
Martin R; Schürenkamp J; Gasse A; Pfeiffer H; Köhler H
Int J Legal Med; 2013 May; 127(3):593-601. PubMed ID: 23183899
[TBL] [Abstract][Full Text] [Related]
18. Stability study of LSD under various storage conditions.
Li Z; McNally AJ; Wang H; Salamone SJ
J Anal Toxicol; 1998 Oct; 22(6):520-5. PubMed ID: 9788528
[TBL] [Abstract][Full Text] [Related]
19. Short-term stability of lysergic acid diethylamide (LSD), N-desmethyl-LSD, and 2-oxo-3-hydroxy-LSD in urine, assessed by liquid chromatography-tandem mass spectrometry.
Skopp G; Pötsch L; Mattern R; Aderjan R
Clin Chem; 2002 Sep; 48(9):1615-8. PubMed ID: 12194952
[No Abstract] [Full Text] [Related]
20. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
